Ikuroh Ohsawa Selected Research

Ikuroh Ohsawa Research Topics

Disease

7	Neoplasms (Cancer) 01/2021 - 08/2002
6	Inflammation (Inflammations) 01/2023 - 03/2013
5	Ischemia 12/2016 - 09/2007
4	Atherosclerosis 11/2018 - 12/2008
4	Reperfusion Injury 12/2016 - 08/2008
3	Neuroblastoma 07/2023 - 12/2002
3	Lung Injury 01/2023 - 01/2019
3	Pneumonia (Pneumonitis) 01/2023 - 01/2019
3	Cognitive Dysfunction 01/2018 - 06/2008
3	Alzheimer Disease (Alzheimer's Disease) 10/2009 - 07/2006
2	Fibrosis (Cirrhosis) 10/2021 - 10/2011
2	Osteoporosis 01/2020 - 09/2012
2	Dementia (Dementias) 01/2018 - 10/2009
2	Body Weight (Weight, Body) 10/2014 - 09/2009
2	Obesity 03/2013 - 07/2011
2	Glioma (Gliomas) 11/2008 - 05/2005
2	Infarction (Infarctions) 08/2008 - 07/2008
2	Cerebral Infarction 07/2008 - 09/2007
1	Retinitis Pigmentosa (Pigmentary Retinopathy) 10/2022
1	Retinal Degeneration 10/2022
1	Sarcopenia 12/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 12/2020
1	Metabolic Bone Diseases (Osteopenia) 01/2020
1	Burns 01/2020
1	Arthritis (Polyarthritis) 10/2019
1	Necrosis 10/2019
1	Interstitial Lung Diseases (Interstitial Lung Disease) 10/2019
1	Hamman-Rich Syndrome (Hamman Rich Syndrome) 01/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019
1	Acute Lung Injury 01/2019
1	Weight Loss (Weight Reduction) 01/2019
1	Lung Neoplasms (Lung Cancer) 01/2019
1	Autosomal Dominant Optic Atrophy (Dominant Optic Atrophy) 11/2017
1	Septic Shock (Toxic Shock Syndrome) 01/2017
1	Wounds and Injuries (Trauma) 01/2017
1	Sepsis (Septicemia) 01/2017
1	Cataract (Cataracts) 01/2016
1	Corneal Edema 01/2016
1	Muscular Atrophy (Muscle Atrophy) 10/2014
1	Atrophy 10/2014
1	Depressive Disorder (Melancholia) 02/2014

Drug/Important Bio-Agent (IBA)

19	HydrogenIBA 01/2023 - 09/2007
11	Proteins (Proteins, Gene)FDA Link 01/2023 - 08/2002
6	AldehydesIBA 01/2020 - 07/2006
5	Mitochondrial Aldehyde DehydrogenaseIBA 01/2020 - 06/2008
4	AntioxidantsIBA 01/2023 - 12/2008
3	LipidsIBA 07/2023 - 03/2013
3	Messenger RNA (mRNA)IBA 01/2023 - 03/2010
3	Aldehyde DehydrogenaseIBA 01/2020 - 09/2012
3	SurvivinIBA 11/2008 - 12/2004
2	LipopolysaccharidesIBA 01/2023 - 01/2017
2	Retinaldehyde (Retinal)IBA 10/2022 - 01/2010
2	Superoxide Dismutase-1IBA 01/2020 - 01/2016
2	AcetaldehydeIBA 01/2020 - 09/2012
2	ErbB Receptors (EGF Receptor)IBA 01/2019 - 11/2008
2	Hormones (Hormone)IBA 01/2017 - 07/2011
2	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 10/2014 - 07/2006
2	Fatty Acids (Saturated Fatty Acids)IBA 03/2013 - 07/2011
2	Glucose (Dextrose)FDA LinkGeneric 03/2013 - 07/2011
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2010 - 09/2007
2	Lipid PeroxidesIBA 10/2009 - 06/2008
2	Drinking WaterIBA 09/2009 - 04/2009
2	ApolipoproteinsIBA 12/2008 - 06/2008
2	Apolipoproteins E (ApoE)IBA 12/2008 - 06/2008
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	Polymethyl Methacrylate (Sol)IBA 12/2021
1	Bleomycin (Blenoxane)FDA LinkGeneric 10/2021
1	AntigensIBA 01/2021
1	MucinsIBA 01/2021
1	Growth Differentiation Factor 15IBA 12/2020
1	astaxanthine (astaxanthin)IBA 01/2020
1	AlkaliesIBA 01/2020
1	EnzymesIBA 01/2020
1	Anti-Citrullinated Protein AntibodiesIBA 10/2019
1	Interleukin-6 (Interleukin 6)IBA 10/2019
1	CollagenIBA 10/2019
1	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2019
1	Gefitinib (Iressa)FDA Link 01/2019
1	naphthaleneIBA 01/2019
1	oxysterol binding proteinIBA 01/2019
1	OSW 1IBA 01/2019
1	CytokinesIBA 01/2019
1	Tyrosine Kinase InhibitorsIBA 01/2019
1	SterolsIBA 01/2019
1	LDL Lipoproteins (beta Lipoproteins)IBA 11/2018
1	LDL Receptors (LDL Receptor)IBA 11/2018
1	oxidized low density lipoproteinIBA 11/2018
1	Apolipoprotein E4IBA 01/2018
1	UbiquinoneIBA 11/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2017
1	Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA 01/2016
1	CatalaseIBA 01/2016
1	Creatine Kinase (Creatine Phosphokinase)IBA 10/2014
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 02/2014
1	Inosine FDA Link 02/2014

Therapy/Procedure

6	Therapeutics 10/2021 - 12/2002
1	Intraperitoneal Injections 01/2023
1	Critical Care (Surgical Intensive Care) 01/2017
1	Phacoemulsification 01/2016
1	Oral Administration 02/2014